Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 4.14 EX-4.14 Fourth Supplemental Indenture to Indenture Dated As of August 11, 2009
- 4.15 EX-4.15 Fifth Supplemental Indenture to Indenture Dated As of August 11, 2009
- 4.16 EX-4.16 Sixth Supplemental Indenture to Indenture Dated As of August 11, 2009
- 4.17 EX-4.17 Seventh Supplemental Indenture to Indenture Dated As of August 11, 2009
- 5.1 EX-5.1 Form of Opinion of Foley Hoag LLP
- 5.2 EX-5.2 Form of Opinion of Perkins Coie LLP
- 5.3 EX-5.3 Form of Opinion of Perkins Coie LLP
- 5.4 EX-5.4 Form of Opinion of Greenberg Traurig P.a.
- 5.5 EX-5.5 Form of Opinion of Greenberg Traurig LLP
- 5.6 EX-5.6 Form of Opinion of Troutman Sanders LLP
- 5.7 EX-5.7 Form of Opinion of Venable LLP
- 12.1 EX-12.1 Statement Regarding Computation of Ratio of Earnings to Fixed Charges
- 12.2 EX-12.2 Statement Regarding Computation of Ratio of Earnings to Combined Fixed Charges and Preference Dividends
- 23.1 EX-23.1 Consent of Bdo Seidman, LLP
- 23.2 EX-23.2 Consent of KPMG LLP
- 23.3 EX-23.3 Consent of Ernst & Young LLP
- 23.4 EX-23.4 Consent of Grant Thornton Zhongua
- 23.5 EX-23.5 Consent of Stonefield Josephson, Inc.
- 25.1 EX-25.1 Statement of Eligibility
- 99.1 EX-99.1 Form of Letter of Transmittal
- 99.2 EX-99.2 Form of Notice Guaranteed Delivery
- 99.3 EX-99.3 Form of Letter to Registered Holders and DTC Participants
- 99.4 EX-99.4 Form of Letter to Clients
Instant similar filings
- 26 Nov 10 Registration of securities issued in business combination transactions
- 19 Apr 10 Registration of securities issued in business combination transactions (amended)
- 26 Mar 10 Registration of securities issued in business combination transactions (amended)
- 12 Feb 10 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.4
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated May 19, 2009, with respect to the combined statements of assets acquired and liabilities assumed of the Second Territory Business of ACON Laboratories, Inc., AZURE Institute, Inc., Oakville Hong Kong Co., Ltd, and ACON Biotech (Hangzhou) Co., Ltd as of December 31, 2008 and 2007, and the related statements of revenue and direct expenses for each of the years ending December 31, 2008 and 2007, appearing in theForm 8-K of Inverness Medical Innovations, Inc. filed on July 1, 2009, which is incorporated by reference in this Registration Statement. We consent to the incorporation by reference in the Registration Statement of the aforementioned report and to the use of our name as it appears under the caption “Experts.”
/s/ Grant Thornton Zhonghua
Shanghai, China
February 12, 2010